Researchers investigating pediatric multiple sclerosis have identified distinct chemical changes in DNA that point toward a biological link with Epstein-Barr virus infections and host immune pathways. The findings, published in the journal Neurology Neuroimmunology & Neuroinflammation, offer new insight into how early environmental exposures might interact with genetic susceptibility to influence disease onset.
Mapping Epigenetic Alterations in Early-Onset Multiple Sclerosis
Multiple sclerosis is an inflammatory condition that harms the brain and spinal cord. While the disease typically manifests in adulthood, it can also develop during childhood or adolescence, a classification known as pediatric-onset multiple sclerosis, or POMS. The exact triggers remain elusive, though scientists widely agree that a combination of genetic risks and environmental factors drives the condition.
Blood Sample Analysis Reveals 55 Differentially Methylated Regions
To explore these mechanisms beyond the standard genetic code, researchers examined epigenetic modifications—specifically DNA methylation. This process involves adding chemical methyl groups to DNA molecules, altering how cells read and activate genes without changing the underlying genetic sequence. The study analyzed blood samples from 122 young people diagnosed with POMS and 53 control participants without the disease, all drawn from Italy.
The analysis revealed 55 differentially methylated regions across the genome that showed significant differences between POMS patients and the control group. Prominent signals appeared in several genes, including CHI3L2, LPCAT1, CD19, PARP1, CPT1B-CHKB, and IGF2R. Several of these altered regions overlapped with genetic locations previously tied to multiple sclerosis risk.
Epstein-Barr Virus Pathways Emerge as a Top Factor
Following the laboratory analysis, the research team ran computer-based evaluations to determine which biological pathways correlated most strongly with the affected genes. Infection with the Epstein-Barr virus—the pathogen responsible for infectious mononucleosis—ranked as the top association in both the primary analysis and subsequent sensitivity testing.
Epstein-Barr virus infection is recognized as one of the strongest environmental risk factors for multiple sclerosis. However, because the virus is exceptionally common, only a small fraction of infected individuals ultimately develop the disease. Differences in genetic susceptibility and other variables likely account for this disparity. In the new study, the Epstein-Barr virus-related signal remained present regardless of whether individual participants had confirmed prior infection records.
Regulatory Interface Between Viral Exposure and Immune Profiles
Despite these correlations, the authors emphasized that the study design cannot establish direct cause and effect. The findings suggest that DNA methylation acts as a regulatory interface connecting early environmental exposures, such as viral infections, with the immune profiles characteristic of pediatric-onset multiple sclerosis. Further research is required to validate these patterns and clarify how specific environmental triggers drive long-term epigenetic shifts.
Keep reading